Join
Live feed
·
PRReleasevia Quantisnow
Cognition Therapeutics Inc. logo

Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CGTX (Cognition Therapeutics Inc.) and more on Quantisnow.